The synthesis of [H-3]L-756,568, an orally active fibrinogen receptor antag
onist, is described. Two synthetic pathways were developed using either bro
moindoles 2a/2b or bromoaryl sulfonamide 11 as the precursor. Use of the br
omoaryl sulfonamide precursor led to [H-3]L-756,568 with higher radiochemic
al purity, higher radiochemical yield, and slightly higher specific activit
y.